Literature DB >> 21076888

The utility of 99mTc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidism.

N Glynn1, N Lynn, C Donagh, R K Crowley, D Smith, C J Thompson, A D K Hill, F Keeling, A Agha.   

Abstract

BACKGROUND: There are conflicting data in the literature about the sensitivity of sestamibi scintigraphy in parathyroid tumour localisation in primary hyperparathyroidism (PHPT). AIM: We aimed to evaluate the overall sensitivity of this modality in parathyroid tumour localisation and to determine clinical and biochemical factors which influence sensitivity of this method.
METHODS: We performed a retrospective review of 57 patients with a biochemical diagnosis of PHPT who had sestamibi scintigraphy performed.
RESULTS: The sensitivity of sestamibi scanning was 56% in whole group and 63% in those without nodular thyroid disease. Among the patients with confirmed single gland disease (biochemical cure after surgical removal of a single adenoma), sensitivity was 71%. A positive scan was associated with younger age, greater adenoma weight and higher pre-operative serum calcium. Concordance between the sestamibi and neck ultrasonography was 92% accurate in pre-operative tumour localisation.
CONCLUSION: Sestamibi scintigraphy was more likely to be positive in younger patients without nodular thyroid disease who have larger parathyroid adenomas with more severe hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076888     DOI: 10.1007/s11845-010-0641-9

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  19 in total

Review 1.  Clinical spectrum of primary hyperparathyroidism.

Authors:  J P Bilezikian; S J Silverberg
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Primary hyperparathyroidism: higher success rate of first surgery after preoperative Tc-99m sestamibi-I-123 subtraction scanning.

Authors:  E Hindié; D Mellière; L Perlemuter; C Jeanguillaume; P Galle
Journal:  Radiology       Date:  1997-07       Impact factor: 11.105

3.  99Tcm sestamibi--a new agent for parathyroid imaging.

Authors:  A J Coakley; A G Kettle; C P Wells; M J O'Doherty; R E Collins
Journal:  Nucl Med Commun       Date:  1989-11       Impact factor: 1.690

4.  Comparison between MR imaging and 99mTc MIBI scintigraphy in the evaluation of recurrent of persistent hyperparathyroidism.

Authors:  M B Gotway; G P Reddy; W R Webb; E T Morita; O H Clark; C B Higgins
Journal:  Radiology       Date:  2001-03       Impact factor: 11.105

5.  Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123.

Authors:  E Hindié; D Mellière; C Jeanguillaume; L Perlemuter; F Chéhadé; P Galle
Journal:  J Nucl Med       Date:  1998-06       Impact factor: 10.057

6.  Relationship between sestamibi uptake, parathyroid hormone assay, and nuclear morphology in primary hyperparathyroidism.

Authors:  Laurent D Biertho; Chun Kim; Hai-Shan Wu; Pamela Unger; William B Inabnet
Journal:  J Am Coll Surg       Date:  2004-08       Impact factor: 6.113

7.  Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study)

Authors:  R Taillefer; Y Boucher; C Potvin; R Lambert
Journal:  J Nucl Med       Date:  1992-10       Impact factor: 10.057

8.  Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy.

Authors:  Damita L Thomas; Twyla Bartel; Yusuf Menda; James Howe; Michael M Graham; Malik E Juweid
Journal:  Clin Nucl Med       Date:  2009-10       Impact factor: 7.794

9.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

Authors:  H Heath; S F Hodgson; M A Kennedy
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

10.  Localization of parathyroid adenomas by sonography and technetium tc 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both studies really needed?

Authors:  Mitchell E Tublin; Daniel A Pryma; John H Yim; Jennifer B Ogilvie; James M Mountz; Badreddine Bencherif; Sally E Carty
Journal:  J Ultrasound Med       Date:  2009-02       Impact factor: 2.153

View more
  3 in total

Review 1.  Low dose four-dimensional computerized tomography with volume rendering reconstruction for primary hyperparathyroidism: How I do it?

Authors:  Timothy A Platz; Moshim Kukar; Rania Elmarzouky; William Cance; Ahmed Abdelhalim
Journal:  World J Radiol       Date:  2014-09-28

2.  Surgical management of primary hyperparathyroidism.

Authors:  Stephen Ryan; Danielle Courtney; Julia Moriariu; Conrad Timon
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-10-16       Impact factor: 2.503

3.  Utility of surgeon-performed pre-operative ultrasound in the localisation of parathyroid adenomas.

Authors:  Paul Rs Thomas; Andrew D Beggs; Thang S Han
Journal:  JRSM Cardiovasc Dis       Date:  2019-06-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.